- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
Patent holdings for IPC class C07D 473/34
Total number of patents in this class: 1061
10-year publication summary
|
83
|
95
|
82
|
66
|
57
|
40
|
52
|
47
|
47
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ono Pharmaceutical Co., Ltd. | 425 |
26 |
| Novartis AG | 10494 |
25 |
| Gilead Sciences, Inc. | 2134 |
25 |
| K36 Therapeutics, Inc. | 26 |
19 |
| Intellikine LLC | 41 |
18 |
| Dana-Farber Cancer Institute, Inc. | 2640 |
17 |
| Amgen Inc. | 4290 |
15 |
| Infinity Pharmaceuticals, Inc. | 99 |
15 |
| Rhizen Pharmaceuticals AG | 55 |
15 |
| Epizyme, Inc. | 366 |
14 |
| Univerzita Palackeho V Olomouci | 136 |
14 |
| AstraZeneca AB | 2833 |
13 |
| Sloan-Kettering Institute for Cancer Research | 561 |
13 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
13 |
| The Regents of the University of California | 20355 |
12 |
| Incyte Corporation | 1037 |
12 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
12 |
| The Scripps Research Institute | 1343 |
12 |
| F. Hoffmann-La Roche AG | 7893 |
11 |
| Gilead Calistoga LLC | 35 |
11 |
| Other owners | 749 |